Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Ingevity Corp
Report date February 26, 2022 · Filed March 01, 2022
Section 16 reporting ended · disclosed 2022-03-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,779 |
Ending reported balance
After 2022-02-28 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-02-26 · Tax withholding · Disposed 261 · Balance 22,248 F1: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on February 26, 2022. Row 2 · 2022-02-28 · Tax withholding · Disposed 131 · Balance 22,117 F2: Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2022. Row 3 · 2022-02-28 · Tax withholding · Disposed 338 · Balance 21,779 F3: Shares withheld by the Company to satisfy tax withholding obligations related to the 2020 RSUs that vested on February 28, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on February 26, 2022.
F2: Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2022.
F3: Shares withheld by the Company to satisfy tax withholding obligations related to the 2020 RSUs that vested on February 28, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2022 Filed Mar 1, 2022 21:10 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 338 | $68.23 | $23,061.74 |
DisclosureSEC source: 0001567619-22-005933 · doc1.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,779 F3 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2020 RSUs that vested on February 28, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:10 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 131 | $68.23 | $8,938.13 |
DisclosureSEC source: 0001567619-22-005933 · doc1.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,117 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2022. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:10 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 261 | $68.23 | $17,808.03 |
DisclosureSEC source: 0001567619-22-005933 · doc1.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,248 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2021 RSUs that vested on February 26, 2022. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative | 3,621 | $0.00 Strike: $53.11 | $0.00 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · derivative · entry 6 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,621 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative | 4,257 | $0.00 Strike: $34.18 | $0.00 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · derivative · entry 5 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,257 shares Expires 2026-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 3,621 | $80.81 | $292,613.01 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · nonDerivative · entry 4 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,509 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 4,257 | $80.81 | $344,008.17 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,130 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | Exercise / conversionCommon Stock | 3,621 | $53.11 | $192,311.31 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 17:29 UTC | Ingevity Corp NGVT · Entity 4401 | Exercise / conversionCommon Stock | 4,257 | $34.18 | $145,504.26 |
DisclosureSEC source: 0001493152-21-027899 · ownership.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 344 | $69.35 | $23,854.68 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 7 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,509 F6 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2020 RSUs that vested on February 28, 2021. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 118 | $69.35 | $8,182.71 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 6 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,853 F5 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2021. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,047 | $69.35 | $72,604.22 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 5 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,971 F4 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2018 RSUs that vested on February 28, 2021. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 154 | $69.35 | $10,679.13 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 4 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,018 F4 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2018 RSUs that vested on February 28, 2021. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 4,614 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · derivative · entry 8 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,614 Underlying: Common Stock · 4,614 shares Expires 2031-02-26 F7 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 2,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,172 F3 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 26, 2022, 2023, and 2024. Read SEC document |
| February 26, 2021 Filed Dec 17, 2021 21:15 UTC Amendment | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 4,614 | $0.00 Strike: $69.48 | $0.00 |
DisclosureSEC source: 0001493152-21-031948 · form4a.xml · derivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,614 Underlying: Common Stock · 4,614 shares Expires 2031-02-26 F1 · derivative.exercise_price: The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). This amendment is being filed solely to correct the exercise price and to correct the signature line of the prior report. F2 · derivative.exercise_date: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024. Read SEC document |
| February 18, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 1,173 | $69.18 | $81,148.14 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,043 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 18, 2021. Read SEC document |
| February 18, 2021 Filed Mar 2, 2021 15:12 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 3,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-21-000020 · wf-form4_161471595696437.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,216 F1 · shares: On February 18, 2021, the Leadership Development and Compensation Committee certified the attainment of the performance goals for certain performance-based restricted stock awards ("PSUs"). The PSUs were settled with shares of common stock. Read SEC document |
| March 05, 2020 Filed Mar 5, 2020 11:24 UTC | Ingevity Corp NGVT · Entity 4401 | PurchaseCommon Stock | 3,000 | $47.13 | $141,390.00 |
DisclosureSEC source: 0001653477-20-000028 · wf-form4_158342545904311.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,603 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 12:29 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 9,318 | $0.00 Strike: $45.04 | $0.00 |
DisclosureSEC source: 0001653477-20-000025 · wf-form4_158325653358301.xml · derivative · entry 4 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,318 Underlying: Common Stock · 9,318 shares Expires 2030-02-28 F4 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 28, 2021, 2022 and 2023. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 12:29 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 3,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-20-000025 · wf-form4_158325653358301.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,603 F3 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2021, 2022, and 2023. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 12:29 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 195 | $44.74 | $8,724.30 |
DisclosureSEC source: 0001653477-20-000025 · wf-form4_158325653358301.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,319 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2019 RSUs that vested on February 28, 2020. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 12:29 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 253 | $44.74 | $11,319.22 |
DisclosureSEC source: 0001653477-20-000025 · wf-form4_158325653358301.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,514 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the 2018 RSUs that vested on February 28, 2020. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 13:14 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 219 | $47.76 | $10,458.35 |
DisclosureSEC source: 0001653477-20-000017 · wf-form4_158291366078692.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,767 F3 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the RSUs that vested on February 27, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 13:14 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 2,674 | $48.67 | $130,143.58 |
DisclosureSEC source: 0001653477-20-000017 · wf-form4_158291366078692.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,986 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 26, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 13:14 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 5,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-20-000017 · wf-form4_158291366078692.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,660 F1 · shares: On February 26, 2020, the Compensation Committee certified the attainment of the performance goals for certain performance-based restricted stock awards ("PSUs"). The PSUs were settled with shares of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 15:52 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 228 | $114.74 | $26,159.58 |
DisclosureSEC source: 0001653477-19-000044 · wf-form4_155147352606222.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,886 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the RSUs that vested on February 28, 2019. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 18:14 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 3,302 | $0.00 Strike: $115.22 | $0.00 |
DisclosureSEC source: 0001653477-19-000060 · wf-form4_155174127141982.xml · derivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302 Underlying: Common Stock · 3,302 shares Expires 2029-02-28 F2 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 28, 2020, 2021, and 2022. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 18:14 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-19-000060 · wf-form4_155174127141982.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,012 F1 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2020, 2021, and 2022. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 15:52 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 218 | $114.23 | $24,901.05 |
DisclosureSEC source: 0001653477-19-000044 · wf-form4_155147352606222.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,114 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the RSUs that vested on February 27, 2019. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 15:52 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 250 | $114.23 | $28,556.25 |
DisclosureSEC source: 0001653477-19-000044 · wf-form4_155147352606222.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,332 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the RSUs that vested on February 27, 2019. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 15:09 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 2,943 | $117.07 | $344,537.01 |
DisclosureSEC source: 0001653477-19-000022 · wf-form4_155086614256607.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,582 F2 · shares: Shares withheld by the Company to satisfy tax withholding obligations related to the PSUs that vested on February 20, 2019. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 15:09 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 6,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-19-000022 · wf-form4_155086614256607.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,525 F1 · shares: On February 20, 2019, the Compensation Committee certified the attainment of the performance goals for certain performance-based restricted stock awards ("PSUs"). The PSUs were settled with shares of common stock. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 13:42 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 3,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-18-000012 · wf-form4_151992973571459.xml · nonDerivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,261 F3 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, all of which will vest in full on February 28, 2021. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 13:42 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-18-000012 · wf-form4_151992973571459.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,923 F2 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan, which will vest in three equal installments on February 28, 2019, 2020, and 2021. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 13:26 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 4,313 | $0.00 Strike: $74.91 | $0.00 |
DisclosureSEC source: 0001653477-18-000021 · wf-form4_152001516395739.xml · derivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313 Underlying: Common Stock · 4,313 shares Expires 2028-02-28 F1 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest in full on February 28, 2021. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 13:42 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 358 | $78.55 | $28,120.90 |
DisclosureSEC source: 0001653477-18-000012 · wf-form4_151992973571459.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 F1 · balance_after: This filing is being made to report the units surrendered back to the Company to satisfy tax withholding obligations related to previously reported restricted stock units that vested on February 27, 2018. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 12:26 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 3,621 | $0.00 Strike: $53.11 | $0.00 |
DisclosureSEC source: 0001653477-17-000024 · wf-form4_148838918761556.xml · derivative · entry 3 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,621 Underlying: Common Stock · 3,621 shares Expires 2027-02-27 F3 · shares: These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest in full on February 27, 2020. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 12:26 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 1,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-17-000024 · wf-form4_148838918761556.xml · nonDerivative · entry 2 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,812 F2 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan which will vest in three equal installments on February 27, 2018, 2019, and 2020. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 12:26 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 213 | $53.48 | $11,391.24 |
DisclosureSEC source: 0001653477-17-000024 · wf-form4_148838918761556.xml · nonDerivative · entry 1 Smith Michael P. · CIK 0001576128 · EVP, President Perf Chemicals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · shares: On June 20, 2016, the reporting person was granted restricted stock units pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan that vest in three equal installments. This filing is being made to report the units surrendered back to the Company to satisfy tax withholding obligations related to the restricted stock units that vested on February 27, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.